Clinical continuity. Technical evidence.Atlant Security
Hospital/PentestBY ATLANT SECURITY

HOSPITAL PENETRATION TESTING

Hospital ransomware-path & recovery testing

Examine access to recovery controls and the dependencies needed to return a clinical service.

Discuss your requirements

The boundary worth testing

Ransomware readiness is wider than confirming a backup job succeeded. Excessive recovery roles, persistent support sessions and missing identity dependencies can undermine an otherwise sound recovery design.

An administrative support session may cross from a vendor access broker into recovery management. A working backup may still depend on an unavailable identity provider before a restored clinical application can be used. We connect these technical details to an agreed service boundary.

What the scope can include

  • Privileged paths into backup and recovery management
  • Supplier session termination and inherited group roles
  • Immutability controls through approved non-destructive checks
  • Isolated service restoration and clinical validation dependencies

The final proposal identifies the specific applications, accounts, environments and interfaces included. It also states which prerequisites your team or a supplier must provide.

What useful proof looks like

Use permission checks and canary objects to establish administrative reach. For an agreed isolated restoration, measure infrastructure readiness separately from application login, integration health and owner acceptance.

Preserve UTC time, asset identifier, requesting principal, expected decision and observed response. State-changing tests need confirmation from the resulting object or a trusted audit record. Denied operations and effective controls remain part of the outcome.

Safety and assessment limits

No encryption exercise, live backup deletion or patient-service outage is part of the default scope. A restore rehearsal does not automatically prove a hospital-wide recovery-time objective.

Agree stop conditions with clinical operations and biomedical engineering. Exclude treatment changes and active interrogation of sensitive devices unless specifically approved. Use a canary clinical workflow, controlled rates and a named on-call decision maker for every test window.

Close the loop

Connect each weakness to a named owner, immediate safeguard and durable correction. Define positive and negative retest cases so the change restores the intended boundary while preserving legitimate use. Open items retain their dependencies and deadlines.

Preview the sector sample report to see the evidence and treatment-plan format.

LET’S START A CONVERSATION

Define the scope.
Take the next step.

Your systems, operating constraints and security objectives. A clear starting point for the test.

Discuss your pentest